(MedPage Today) — The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency announced Monday.
The treatment is a subcutaneous injectable formulation of copper histidine that aims…
Source link : https://www.medpagetoday.com/neurology/generalneurology/119404
Author :
Publish date : 2026-01-13 20:47:00
Copyright for syndicated content belongs to the linked Source.
